From February 2, 2024 to March 31, 2024, the company has repurchased 21,874,798 shares, representing 1.35% for CNY 97.38 million. With this, the company has completed the repurchase of 21,874,798 shares, representing 1.35% for CNY 97.38 million under the buyback announced on February 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.33 CNY | -0.47% | -2.31% | -11.96% |
Apr. 28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.96% | 1.4B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.